chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer and described the occurrence of fever in a 4-month-old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix) for prophylaxis. The reporter is the mother of the subject. A physician or other health care professional has not verified this report.  Concurrent medical conditions included gastroesophageal reflux. Concurrent medications included Famotidine (Pepcid). On 28-October 2004, the subject received 1st dose of Pediarix (lot AC21A007AA). On 28 October 2004, the subject also received Haemophilus influenzae type b conjugate vaccine (non, unknown manufacturer). On 28 October 2004, at 10:00 p.m., less than one day after vaccination with Pediarix, the subject experienced fever. The fever resolved on 29 October 2004. On  03 January 2005, the subject again experienced a fever. The subject was seen at a physician's office. The fever resolved on an unspecified date before 08 March 2006. On an unspecified date on or before 08 March 2006, the subject received the 3rd dose of Pediarix. The mother of the subject reported that the subject "did not experience fever with the 3rd dose" of Pediarix. Follow-up information received via the mother in an authorization to contact physician indicated that the subject's fever went to 105 degrees. The physician and her nurse instructed the mother to treat her son's fevers with Tylenol. No additional details were received at the time of reporting.
Morning after vaccine administered, had swollen matted eye lid (right), swollen (right) upper and lower lips.  Vaccine administered shortly after 3pm, and symptions appeared the following day approximately at 3:30AM.  Treatment:  hot compress over eyes, then 6:30AM ice to lip areas.  RESOLVED
pt recvd vax 6AUG93 & 6AUG93 devel a localized react w/red, hot swollen inject site; rt arm was burning & itching & had a localized rash; exp pain from the rt elbow to the neck & blurred vision; t99.3; dx migraine; also n,v,d & dizziness
node swelling; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (node swelling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (node swelling). At the time of the report, LYMPHADENOPATHY (node swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant information  provided. No Treatment information  provided
Numbness began in left hand fingertips which spread to face, mouth, tongue. Always on left side and never fully numb. I also got extremely tired and could not stay awake at moments or speak clearly (inside my head I knew I wasn?t speaking clearly but I couldn?t fix it) . Day following vaccine I began to have bad pain on top of my ankles at the bend with my top of foot. This got pretty bad that someone needed to massage it regularly to alleviate some of the pain. This went on regularly until a couple of days  prior to my second shot.  Brain fogging has improved over time. Some dizziness still remains. I had a very bad headache for about three weeks. Interestingly my reaction to shot two on 6/7/2021 has been nothing like the first shot. I?ve had some bad pain in the left wrist and more at site of injection pain but much better than first round.
This spontaneous report was received from a 66-year-old female patient who was reporting on herself. The patient did not take any concomitant medications and did not have any known drug reactions and allergies. There was no information about the patient's medical history provided. On 09-NOV-2016, the patient was vaccinated with a dose of PNEUMOVAX23, 0.5 ml, intramuscularly in the right arm for prophylaxis (lot# and expiration date were not reported). Other suspect therapies included unspecified influenza virus vaccine administrated to the patient on 09-NOV-2016 in left arm. On 09-NOV-2016, reported as later the same evening, the patient felt pain in the right shoulder. She could not open car door or raise right arm past hips. Her arm was extremely painful, red and swollen, and she felt the pain circling from arms to shoulders. The patient could not roll over without experiencing terrible pain. The patient took TYLENOL for the pain and applied ice. The patient stated that the following day, reported as in the morning, she felt better and less pain. The patient called to the physician, on an unknown date and had unspecified laboratory diagnostic studies performed, on an unknown date (results were not provided). The outcome of the pain was reported as recovering. The outcome of the other events were reported as not recovered. The relatedness between the events and PNEUMOVAX23 was not reported. Additional information is not expected because there was no consent to contact the physician.
Mom states child developed chest rash at noontime on 5/16/03. On 5/20 Saturday morning, the child had generalized body rash - pinpoint only. No raised areas. Had mild fever on Friday, but no fever or other complaints on Saturday. No itch or fussiness.
Intussusception 7 weeks 5 days after ROTATEQ #2. Intussusception successfully reduced in radiology.
Accompanied by parent, post vaccination reports "feeling dizzy"; denies any additional complaints on assessment. Medical monitoring  x15m, po hydration offered / H20 consumed, vitals obtained: HR 94  BP 118/75  O2 sat 99%RA.  Reports "feeling fine", with no other complaints reported/ symptoms resolve; released from mobile facility w/parent-mother.
PATIENT FELT DIZZY, LIGHT HEADED AND VOMITING AFTER SHOT
booster dose; fatigue; arm ached; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Amylodosis" (unspecified if ongoing), notes: Patient has amylodosis and had stem cell transplant 6 years ago; "had stem cell transplant" (unspecified if ongoing), notes: Patient has amyloidosis and had stem cell transplant 6 years ago. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, fatigue after all three shots), for Covid-19 Immunization, reaction(s): "fatigue"; Bnt162b2 (Dose: 1, her arm ached longer after receiving the booster dose than the first 2 shots.), for Covid-19 Immunization, reaction(s): "arm ached"; Bnt162b2 (Dose: 2, fatigue after all three shots), for Covid-19 Immunization, reaction(s): "fatigue"; Bnt162b2 (Dose: 2, her arm ached longer after receiving the booster dose than the first 2 shots.), for Covid-19 Immunization, reaction(s): "arm ached". The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster dose"; FATIGUE (non-serious), outcome "unknown", described as "fatigue"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm ached".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Day 9 after vaccine dose 1, I woke with armpit pain in both armpit, pain and skin hypersensitivity down both arms to the elbows, torso and back.  The hip joint on both sides also ached.  Days 10-11 the skin hypersensitivity was intense and painful. I took Benedryl and ibuprofen to sleep at night. Day 12 the pain was limited to the left arm only and I developed two sores in my mouth.  By day 13 the pain was gone and by Day 15 the mouth sores were gone.  I am unsure if I should get the second dose which is scheduled on 2/25/2021.
1 day after injection, patient had erythema and induration measuring 2x3 inches on R upper arm.
15 minutes after shot: significant, noticeable swelling and pain in injection arm, flushed face, neck, and chest; 30 minutes after shot: swelling in face, discomfort in throat, tingling in limbs, anxiety, heart rate increase.  Pretreated with benadryl (25mg) 30 minutes prior (at 3 pm); pretreated with benadryl  (25mg) 10 minutes prior (3:20pm).   Left pharmacy at 3:45, drove to ER as symptoms were worsening. Waited at ER (not triaged) until symptoms significantly subsided - around 5:15pm.   Continued benadryl every 4 hours for 12 hours (tried delaying benadryl at 7:30pm, but symptoms began returning). The reduced to 25mg every 5-6 hours, for 24 hours (symptoms returned without benadryl).  Other side effects: Began ~ 7 pm: temperature spikes and drops (hands and feet freezing cold), chills, stomach pain, nausea, extreme headache, extreme muscle pain and joint pain, shooting pain, fatigue.  400 mg ibuprofen every 4-6 hours. first 24 hours very bad, 36 hours reesolved,
With the first vaccine I developed a slightly phlegmy cough, the cough seemed to progress to a point to where I experienced a shortness of breath. It has become more intense, so bad that one night I woke up wheezing and gasping for air. I was sent to a respiratory therapist, I ended up with different kinds of inhalers. This is something that has just kept going even after the second vaccine.
Heart attack; Pericarditis; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack) and PERICARDITIS (Pericarditis) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criterion medically significant) and PERICARDITIS (Pericarditis) (seriousness criterion medically significant). The patient was treated with COLCHICINE for Pericarditis, at a dose of .6 mg once a day; IBUPROFEN for Pericarditis, at an unspecified dose and frequency and GLYCERYL TRINITRATE (NITRO [GLYCERYL TRINITRATE]) for Heart attack, at a dose of 3 shots. At the time of the report, MYOCARDIAL INFARCTION (Heart attack) outcome was unknown and PERICARDITIS (Pericarditis) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Laboratory test: unknown Results were unknown.         Concomitant product was not provided by the reporter.  Patient reported that within 20 hours of receiving second dose of moderna vaccine he experienced pericarditis. Patient went to the emergency room (ER) because he thought he was having a heart attack, doctor thought so too hence he was given 3 shots of Nitro.  He was not admitted.  They ran lots of other tests. He was otherwise healthy, took no other medications. The patient went for a follow-up appointment three weeks back and still had it, and had not gone away yet. Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, more information is required for further assessment.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, more information is required for further assessment.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with expired dose of VARIVAX lot # L003775, expiration date: 04-FEB-2017 for prophylaxis (route and site of administration were not reported). No adverse effects were reported. Additional information has been requested.
Pt received vaccine on 3/29.  Pt was attending dialysis treatments as scheduled until 4/12.  Pt called and stated his legs hurt and he was not feeling well.  Pt went to hospital and another hospital and both hospitals did not admit patient.  Patient contacted a home physician that came out to the house on 4/14, and sent patient directly to the hospital where patient is today.
Patient called on 9/22 and reported to pharmacist that on 9/21 she had redness in multiple areas of the body. She went to the doctor and doctor advised her it was a reaction from the flu shot she received. She proceeded to take 1 dose of BENADRYL and recovered on 9/23/20. On 9/24 the pharmacist spoke with staff at Dr.'s office and she confirmed they are aware of the reaction. Staff reported that patient did not have issues with regular flu shot in the past. She has never received a high dose flu shot.
Immense back pain; vomiting; Nausea; super fatigued; Migraine; not sleeping or sleeping over 20 hours.This has been happening for 5 days; This is a spontaneous report from a contactable other healthcare professional, the patient. A 24-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID 19 mRNA VACCINE; lot number:en6206) via an unspecified route of administration in left arm, on 12Mar2021 at 16:45 (at the age of 24-year-old),as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medication included citalopram (CELEXA) for unknown indication from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced Immense back pain, vomiting, nausea, fatigue, migraine and difficulty sleeping on 14Mar2021 at 00:00. The patient did not receive any treatment for the reported events. The clinical outcome of Immense back pain, vomiting, nausea, fatigue, migraine and difficulty sleeping was not recovered.   No follow-up attempts are needed. No further information is expected.
About 2 days after the shot an oval red mark showed up on my upper chest. Over the next 2 weeks more no more spots showed up mostly on my chest and back. A few were on my neck, legs, and arms.  Since it kept getting worse I decided to contact my doctor after 2 weeks. My doctor diagnosed it as Pityriasis Rosea.  It is now 2 week 5 days post shot & my rash is still present.
headache; fatigue; This is a spontaneous report from a contactable consumer(parent) via medical information team.A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: FF2595 and expiry date was not reported) via an unspecified route of administration, on an unknown date, as Dose 3(Booster), single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot numbers and expiry dates were not reported) via an unspecified route of administration, on an unknown date, as Dose 1 and Dose 2, single, for covid-19 immunisation. The patient experienced headache and fatigue on an unspecified date. The outcome of the event was unknown at the time of report.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I woke up to 9/13/2022 with a very runny nose at 03:00AM. My nose was running like a faucet that I could not turn off. I decided to take the 3 at home test that I received in the mail and instantly they came back positive. I decided to order 2 more and they arrived the next day on 09/14/2022 and those results were positive. I was able to contact my primary care doctor via telehealth and he prescribed  Paxlovid that day. I was very fatigue and just felt completely down, it felt as if I had a head cold. Now my concentration has not been the same and I am still feeling fatigue after 10 days of testing negative.
Dr. ordered 5th dose of DTaP to be given but a Tdap was accidently given. No adverse Sx from shot.
Pt has experienced seizure events and amnesia. She is continuing to undergo extensive evaluations. Events started around April 22, 2021.
6-20 Varivax administer SQ right upper arm. 6-21-07 Mom noted injection site red, swollen, warm to touch. Called CNOC instructed to see doctor next per mom - swelling better. Continue with redness and warm to touch. Per doctor should continue to heal on it's own.
5 mins follow injection, swelling of mouth and lips, given BENADRYL and ZANTAC.
Encephalitis symptoms: stiff neck, headache lasting more than 7 days, trouble thinking, trouble concentrating, slurred speach
Cellulitis of (R) upper arm. Red, hot to the touch with a lump.
pt recvd vax;9 days later, T 106; given advil q 4 hrs;28feb & 19feb fever for 48 hrs;CBC=neg, strep neg; 20feb95;
30SEP devel pruritic rash, stomach, legs & arms; 4OCT rash extended to back & face; no temp, cough, conjunctivitis or rhinitis;
round raised redness approximately 2 to 3  inch diameter,  Itchiness for two weeks.   No fever  no abscess or sign of infection No help with Benadryl
Patient called stating four days after shot, started to have pain in arm and was black and blue. Had been taking pain relievers and ice pack around the clock. Referred patient to PCP for follow - up and to continue until seen.
Fever 100.2, muscle joint ache, general malaise x 24 hours.
12/21/20 Moderna Covid vaccine 1/19/21 Moderna Covid vaccine 8/6/21 ill 8/7/21 tested  + Covid PCR test 8/17/21 potential to RTW
This spontaneous report as received from a doctor of pharmacy refers to two patients of unknown age and gender. It was reported that 2 patients were vaccinated with a dose of PNEUMOVAX 23 (Lot # reported as 09332, exp 25-FEB-2012) on 25-OCT-2012. No adverse symptoms were reported. Additional information has been requested.
Case number PHEH2013US024171 is an initial spontaneous report received from a pharmacist on 15 Nov 2013: This report refers to a 15-year-old female patient who was inadvertently vaccinated with FLUCELVAX, (batch number: 009021A) intramuscularly on 14 Nov 2013. No adverse event was reported following this administration error.
day after injection pain in arm then turned into lymphadenopathy supracalvicular.  painful lump on right clavicle area, pain swelling under right arm pit, running to breast area.  numbness right small finger, right facial area some decreased sensation, cold sore starting left upper lip. headache , slight nausea and fatigue. By day 3 , 8/9/21 late evening moderate to severe headache, heart palpitations, extreme nausea and dry heave, fatigue, general aches,  all night into morning which is now 8/10/21. Had to call in sick for work.
Client came in to clinic and reported that he had developed hives two days after receiving injections of Td and MMR. Client did seek medical care and was instructed by MD to use Benadryl which he could buy at local drugstore. Client was told he would need a note from MD in the future before receiving any vaccines at clinic. 03/15/2005- P/C made to follow up client completely resolved.
Discharge Provider:  Primary Care Provider: DO Admission Date: 9/6/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Severe sepsis [A41.9, R65.20] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1]   HOSPITAL COURSE:     Patient is a 78 y/o man with past medical history significant for chronic obstructive pulmonary disease with chronic hypoxic respiratory failure on 2 L, chronic systolic CHF, history of MI, coronary artery disease s/p CABG, OSA, hypertension, HDL, PTSD, BPH who presented to the emergency department with complaints of shortness breath.       Upon arrival to emergency department, patient was febrile, mildly tachycardic and tachypneic.  He was stable on his home 2 L O2.  Baseline blood work was obtained and independently reviewed.  Blood work including a complete blood count and CMP were grossly unremarkable.  BNP and lactic acid WNL.  Procalcitonin 0.14.  Patient was given a 1 L NS bolus and Zosyn for suspected infection.  COVID PCR did return positive.  CXR showing patchy basilar and peripheral airspace opacities.  He was given a dose of Decadron and Tylenol for his fever.  Patient was then admitted to General Medicine for further evaluation and management.   Due to worsening of oxygen requirement he was started on remdesivir on 09/07 and completed 5 day course  on 09/11. Completed 7 days of Dexamethasone while in hospital.respiratory condition is improved to baseline.
The patient experienced dizziness, lightheadedness a few minutes after receiving the vaccine, he also complained of sweating and chills. I gave him some water to drink and mountain dew, and I had him lay on his back for several minutes. The patient said he felt better and more alert after laying on the floor. After 10 minutes, I had him sit back up, he was feeling much improved. After 10 more minutes, he wanted to get a snack before he left. I requested he come back after the snack just to check in on him after he had walked around. The patient left the pharmacy feeling normal again.
"Administered - 4/19, time unknown Adverse event started - 10:06 Patient had syncope, flushing/sweating. BP 109/53 -- > 114/55, HR 68 -- >64, RR 16 -- >16 , O2 100% -- > 99%, Temp 97.3F. Given PO juice, Graham crackers. Patient stable, released from vaccination site."
Dizziness, Myalgia, Arthralgia, Tachycardia, 12/29 fatigue, chills
Two days after first shot had shooting pain in left jaw.  Again on 4th day following.  Five days following had debilitating, crippling shooting pain.  Went to ER and treated with morphine, demoral, lidocaine drip and topical lidocaine. sent home with a perscription for carbamazepine 220 mg.  Took the meds for a few weeks and symptoms were under control. Two days after the second vaccine symptoms returned which then needed to increase with a supplemental 100 mg carbamazepine. Note checked disability below because unable to work with the pain.
Redness, swelling, hard lump, bruising  started ~ 12 hrs after injection, worsened  by day 2 at Prevnar site  Treatment - marked redness with skin marker  Ice & Ibu/Tylenol if bothering pt.
pt recv vax 20MAY96 & devel bumps on legs, 26MAY96 in the evening, they resembled hives per mom;then by 2PM 27MAY96, pt completely covered w/bumps, puffy face, swollen around eyes, puffy feet;pt taken to ER;parents told allerg to MMR
At the time of the report, the patient has not yet received the second dose in the series; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose of Shingrix received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 10-Aug-2022 Reporter comment: The pharmacist reported that patient received first dose of Shingrix and now wanted the second dose. At the time of the report, the patient had not yet received the second dose in the series. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
febrile seizure. Was uncontrollably shaking for a few minutes but still conscious. Was grunting with her breathing for about an hour after.